Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
1.020
-0.170 (-14.29%)
At close: Aug 12, 2026, 4:00 PM EDT
1.080
+0.059 (5.83%)
After-hours: Aug 12, 2026, 7:04 PM EDT
Indaptus Therapeutics Market Cap
Indaptus Therapeutics has a market cap or net worth of $115.51 million as of August 12, 2026. Its market cap has increased by 1,278.54% in one year.
Market Cap
115.51M
Enterprise Value
114.01M
1-Year Change
1,278.54%
Ranking
Category
Stock Price
$1.02
ChartMarket Cap Chart
Since August 4, 2021, Indaptus Therapeutics's market cap has increased from $47.95M to $115.51M, an increase of 140.89%. That is a compound annual growth rate of 19.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 115.51M | 2,166.68% |
| Dec 31, 2025 | 5.10M | -49.63% |
| Dec 31, 2024 | 10.12M | -31.58% |
| Dec 29, 2023 | 14.79M | 21.38% |
| Dec 30, 2022 | 12.18M | -73.92% |
| Dec 31, 2021 | 46.70M | -2.60% |
| Aug 4, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cibus | 145.79M |
| Canton Strategic Holdings | 144.22M |
| NRx Pharmaceuticals | 140.40M |
| Equillium | 138.47M |
| Unicycive Therapeutics | 137.51M |
| TuHURA Biosciences | 136.92M |
| Connect Biopharma Holdings | 135.37M |
| ProMIS Neurosciences | 132.00M |